Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Mixed |
| Diagnostics & Research (Global) | Mixed | Mixed | |
| Stock | ICON plc | Bullish | Bullish |
Stockmoo Score
0.5
|
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Mid Growth |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Wcm Investment Management, Llc | 30 Jun 2024 | 6,673,480 |
| Massachusetts Financial Services Co /Ma/ | 30 Jun 2024 | 5,003,492 |
| Ninety One Uk Ltd | 30 Jun 2024 | 2,678,340 |
| Clearbridge Investments, Llc | 30 Jun 2024 | 1,508,463 |
| Comgest Global Investors S.A.S. | 30 Jun 2024 | 1,230,525 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 383.00 (Truist Securities, 26.60%) | Buy |
| Median | 376.00 (24.29%) | |
| Low | 350.00 (Barclays, 15.70%) | Buy |
| Average | 369.67 (22.20%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 322.61 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 26 Jul 2024 | 350.00 (15.69%) | Buy | 323.46 |
| Truist Securities | 26 Jul 2024 | 383.00 (26.60%) | Buy | 323.46 |
| Baird | 08 Jul 2024 | 376.00 (24.29%) | Buy | 320.92 |
| Date | Type | Details |
|---|---|---|
| 03 Sep 2024 | Announcement | ICON plc to Present at the Baird 2024 Global Healthcare Conference |
| 14 Aug 2024 | Announcement | ICON Announces Appointment of New Chief Financial Officer |
| 24 Jul 2024 | Announcement | ICON announces results of Annual General Meeting and changes to the Board of Directors |
| 24 Jul 2024 | Announcement | ICON Reports Second Quarter 2024 Results |
| 10 Jul 2024 | Announcement | ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer |
| 01 Jul 2024 | Announcement | ICON plc Schedules Second Quarter 2024 Earnings Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |